Neoscreen IRT EIA Kit
- UID
- MFG/IVD/2020/000053_fb967a5e52937e5fb92434bfb45e62c4_03f38ba9937025a28380fa272d64986b
- Device class
- Class C
- Brand name
- Immunoreactive Tripsinogen
- License holder
- Trivitron Healthcare Pvt. Ltd
- Approving authority
- Central Drug Standard Control Organisation, South Zone
- Product information
- Labsystem Diagnostics Neoscreen IRT EIA test is a simple competition Enzyme immunoassay enabling the quantification of immunoreactive Trypsinogen present in blood samples dried on filter paper
Neoscreen IRT EIA Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000053_fb967a5e52937e5fb92434bfb45e62c4_03f38ba9937025a28380fa272d64986b. This device is marketed under the brand name Immunoreactive Tripsinogen. The license holder is Trivitron Healthcare Pvt. Ltd, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.